Starting clozapine in patients with schizophrenia during the ongoing pandemic

Detalles Bibliográficos
Autores principales: Grover, Sandeep, Naskar, Chandrima, Sahoo, Swapnajeet, Mehra, Aseem, Chakrabarti, Subho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295063/
https://www.ncbi.nlm.nih.gov/pubmed/34303594
http://dx.doi.org/10.1016/j.schres.2021.07.004
_version_ 1783725364082638848
author Grover, Sandeep
Naskar, Chandrima
Sahoo, Swapnajeet
Mehra, Aseem
Chakrabarti, Subho
author_facet Grover, Sandeep
Naskar, Chandrima
Sahoo, Swapnajeet
Mehra, Aseem
Chakrabarti, Subho
author_sort Grover, Sandeep
collection PubMed
description
format Online
Article
Text
id pubmed-8295063
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-82950632021-07-22 Starting clozapine in patients with schizophrenia during the ongoing pandemic Grover, Sandeep Naskar, Chandrima Sahoo, Swapnajeet Mehra, Aseem Chakrabarti, Subho Schizophr Res Letter to the Editor Elsevier B.V. 2022-05 2021-07-22 /pmc/articles/PMC8295063/ /pubmed/34303594 http://dx.doi.org/10.1016/j.schres.2021.07.004 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Grover, Sandeep
Naskar, Chandrima
Sahoo, Swapnajeet
Mehra, Aseem
Chakrabarti, Subho
Starting clozapine in patients with schizophrenia during the ongoing pandemic
title Starting clozapine in patients with schizophrenia during the ongoing pandemic
title_full Starting clozapine in patients with schizophrenia during the ongoing pandemic
title_fullStr Starting clozapine in patients with schizophrenia during the ongoing pandemic
title_full_unstemmed Starting clozapine in patients with schizophrenia during the ongoing pandemic
title_short Starting clozapine in patients with schizophrenia during the ongoing pandemic
title_sort starting clozapine in patients with schizophrenia during the ongoing pandemic
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295063/
https://www.ncbi.nlm.nih.gov/pubmed/34303594
http://dx.doi.org/10.1016/j.schres.2021.07.004
work_keys_str_mv AT groversandeep startingclozapineinpatientswithschizophreniaduringtheongoingpandemic
AT naskarchandrima startingclozapineinpatientswithschizophreniaduringtheongoingpandemic
AT sahooswapnajeet startingclozapineinpatientswithschizophreniaduringtheongoingpandemic
AT mehraaseem startingclozapineinpatientswithschizophreniaduringtheongoingpandemic
AT chakrabartisubho startingclozapineinpatientswithschizophreniaduringtheongoingpandemic

Ejemplares similares